Drug Trial Radar · NCT04373564
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Last checked: Nov 19, 2026Latest source record: Jan 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
2,076
Planned (sponsor's estimate)
Start
Mar 24, 2021
Primary completion
Dec 31, 2028
Study completion Dec 31, 2028
Sponsor
- Lead sponsor
- GuerbetIndustry
- Sponsor type
- Industry
- Collaborators
- Bayer AG (Sponsor); Bracco (Sponsor); GEHC (Sponsor)
- First posted
- May 4, 2020
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a postmarketing requirement jointly carried out by four NDA holders (Bayer AG, Bracco, GE Healthcare and Guerbet) and the CRO IQVIA. The study aims to create detailed images of the organs and tissue of the human body during x-ray, CT-scan or MRI investigations, doctors are using contrast media (a kind of dye) which can be given to patients by injection into a blood vessel or by mouth. In this study researchers want to find out whether so called gadolinium-based contrast agents (GBCAs) have an effect on body movement and mental skills when given to participants multiple times within 5 years. The study plans to enroll about 2076 participants suffering from a condition for which they are likely to have at least annually a MRI or another imaging examinations. Only adults up to 65 years will be considered to join this study. During the study duration of 5 years participants will receive annually a MRI or other imaging tests (such as CT-scan, x-ray) and will visit the study doctor at least 7 times for physical examinations, laboratory investigations and tests on body movement and mental skills.
Conditions
- Motor Function
- Cognitive Function
- Contrast Media
Interventions
Motor TestsProcedure
To assess motor function annually
Cognitive TestsProcedure
To assess cognitive function annually
Unenhanced-MRI of the brainProcedure
The UE-MRI of the brain will be performed at baseline and at the year 5 visit in order to exclude presence of a significant MRI abnormality
Gadolinium MeasurementsProcedure
Blood samples and spontaneous urine specimens will be collected through the course of the study to measure Gd concentration
Gadoxetate disodiumDrug
Administered as defined by the treating physician as part of routine clinical practice
Gadobenate dimeglumineDrug
Administered as defined by the treating physician as part of routine clinical practice
GadodiamideDrug
Administered as defined by the treating physician as part of routine clinical practice
Gadoterate meglumineDrug
Administered as defined by the treating physician as part of routine clinical practice
GadobutrolDrug
Administered as defined by the treating physician as part of routine clinical practice
GadoteridolDrug
Administered as defined by the treating physician as part of routine clinical practice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change of motor function from baseline to year 5 in comparison to a matched non-GBCA-exposed control groupTime frame: At baseline, year 5
- Change in cognitive function from baseline to year 5 in comparison to a matched non-GBCA-exposed control groupTime frame: At baseline, year 5
Locations
51 sites in 8 countries. Site status is shown where the registry gives one.
Scottsdale Medical Imaging, LLC
Scottsdale, Arizona · Recruiting
Yale University School of Medicine
New Haven, Connecticut · Withdrawn
University of Chicago Medical Center
Chicago, Illinois · Recruiting
Methodist Medical Center of Illinois
Peoria, Illinois · Recruiting
Massachussets General Hospital
Boston, Massachusetts · Recruiting
Boston University Medical Center
Boston, Massachusetts · Terminated
Beth Israel Deaconess Medical Center
Boston, Massachusetts · Withdrawn
ActivMed Practices & Research, Inc.
Methuen, Massachusetts · Withdrawn
University of Massachusetts Memorial Medical Center
Worcester, Massachusetts · Terminated
Department of Radiology
St Louis, Missouri · Withdrawn
UNC School of Medicine
Chapel Hill, North Carolina · Withdrawn
Penn State Hershey Medical Center
Hershey, Pennsylvania · Recruiting
Albert Einstein Healthcare Network
Philadelphia, Pennsylvania · Recruiting
UT Southwestern Medical Center
Dallas, Texas · Recruiting
MD Anderson Cancer Center
Houston, Texas · Withdrawn
University of Wisconsin
Madison, Wisconsin · Recruiting
CEMEC - Oncológica
São Bernardo do Campo, Brazil · Withdrawn
Hospital Santa Marta
Taguatinga, Federal District, Brazil · Terminated
Liga Norte-Rio-Grandense Contra o Câncer
Natal, Rio Grande do Norte, Brazil · Withdrawn
Instituto Mederi de Pesquisa e Saude
Passo Fundo, Rio Grande do Sul, Brazil · Recruiting
Hospital Moinhos de Vento
Porto Alegre, Rio Grande do Sul, Brazil · Recruiting
Instituto Baía Sul de Ensino e Pesquisa (IEP)
Florianópolis, Santa Catarina, Brazil · Withdrawn
CEMEC - Oncológica
São Bernardo do Campo, São Paulo, Brazil · Withdrawn
Fundação Faculdade Regional de Medicina de São José do Rio Preto
São José do Rio Preto, São Paulo, Brazil · Recruiting
CPCLIN - Centro de Pesquisas Clínicas Ltda.
São Paulo, São Paulo, Brazil · Terminated
Albert Einstein Sociedade Beneficente Israelita Brasileira
São Paulo, São Paulo, Brazil · Recruiting
G. Kenneth Jansz Medical Professional Corporation
Burlington, Ontario, Canada · Withdrawn
Groupe Hospitalier Pitie-Salpetriere
Paris, France · Withdrawn
CHU Strasbourg - Hôpital Hautepierre
Strasbourg, France · Recruiting
Vivantes Klinikum Neukoelln
Berlin, Germany · Recruiting
Universitaetsklinikum Tuebingen
Tübingen, Baden-Wurttemberg, Germany · Active not recruiting
Ospedale San Raffaele
Milan, Italy · Recruiting
Università Campus Bio-Medico di Roma
Roma, Italy · Recruiting
Azienda Ospedaliera Universitaria Integrata Verona (Ospedale Borgo Roma)
Verona, Italy · Recruiting
A.O.U. Senese Policlinico Santa Maria alle Scotte
Siena, Siena, Italy · Recruiting
Azienda Ospedaliera Universitaria di Trieste
Trieste, Trieste, Italy · Recruiting
BHI of Omsk region "Clinical Oncology Dispensary"
Omsk, Russia · Suspended
FSBI "National medical scientific center of psychiatry and neurology n.a. V.M. Bekhterev" Adolescent
Saint Petersburg, Russia · Suspended
FSBI North-West Federal Medical Research Center n.a. V.A. Almazov of MoH RF
Saint Petersburg, Russia · Suspended
LLC Medical Center Mart
Saint Petersburg, Russia · Suspended
Showing 40 of 51 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.